← Every applicant
Sunshine FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| RIVAROXABANNew drugMay 14, 2025TABLET, ORAL |
| ARIPIPRAZOLENew drugOct 2, 2023TABLET, ORAL |
| METOPROLOL SUCCINATENew drugSep 26, 2022TABLET, EXTENDED RELEASE, ORAL |
| BRIVARACETAMNew drugJun 9, 2022TABLET, ORAL |
| OSELTAMIVIR PHOSPHATENew drugJan 5, 2022FOR SUSPENSION, ORAL |
| LINAGLIPTINNew drugAug 31, 2021TABLET, ORAL |
| LINAGLIPTIN AND METFORMIN HYDROCHLORIDENew drugAug 30, 2021TABLET, ORAL |
| DULOXETINE HYDROCHLORIDENew drugFeb 11, 2021CAPSULE, DELAYED REL PELLETS, ORAL |